UK pharma major AstraZeneca (LSE: AZN) has gained US approval for Koselugo (selumetinib) in adults with neurofibromatosis ...
Industry analyst GlobalData has highlighted the significance of US pharma major Merck's (NYSE: MRK) plan to buy US biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback